GW Pharma (GWPH) Posts Q1 Loss of 9c/Share

GW Pharma (NASDAQ: GWPH) reported Q2 EPS of ($0.09), $1.48 better than the analyst estimate of ($1.57). Revenue for the quarter came in at $3.81 million versus the consensus estimate of $5.99 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
• Investing.com’s stocks of the week